Platelet intracellular calcium is not modified by subcutaneous administration of erythropoietin.
Lo Cascio
C
C
Guzzo
P
P
Loschiavo
C
C
Manzato
F
F
Lechi
C
C
D001792:Blood Platelets / Q000737:chemistry / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects; D002118:Calcium / Q000097:blood*; D002121:Calcium Channel Blockers / Q000494:pharmacology / Q000627:therapeutic use; D004921:Erythropoietin / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007279:Injections, Subcutaneous; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000494:pharmacology; D006435:Renal Dialysis; D013917:Thrombin / Q000494:pharmacology; D001620:beta-Thromboglobulin / Q000032:analysis
D002121:Calcium Channel Blockers; D011994:Recombinant Proteins; D001620:beta-Thromboglobulin; D004921:Erythropoietin; D013917:Thrombin; D002118:Calcium